Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON55097Active, not recruiting
Open-label, single-arm trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by TNO. Primary endpoints: Percent change in PTSD diagnosis and Frequency and severity of PTSD symptoms. Started Apr 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON55097.